In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone‐3‐O‐sulphamate
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Many tumours in endocrine‐sensitive tissues, such as the breast and endometrium, are hormone‐dependent and the hydrolysis of oestrone sulphate (EIS) to oestrone by oestrone sulphatase (EI‐STS) is a major source of oestrogen in such tumours. Oestrone‐3‐O‐sulphamate (EMATE) has been shown to be a potent EI‐STS inhibitor in vitro, and in this study its ability to inhibit enzyme activity in vivo was examined. EMATE was initially administered to female rats for 7 days, after which liver EI‐STS activity was measured. As EMATE also inhibits a related sulphatase in vitro, dehydroepiandrosterone sulphatase (DHA‐STS), its effect on the activity of this enzyme in vivo was also investigated. DHA‐STS has a pivotal role in regulating the synthesis of another steroid with potent oestrogenic properties, androstenediol. Administration of EMATE almost completely inhibited liver EI ‐STS (99%) and DHA‐STS (99%) activities and was active when given by the oral or subcutaneous routes. After a single dose of EMATE or following the cessation of multiple doses for 10 days, liver EI‐STS activity remained inhibited (>95%) for up to 7 and 10 days, respectively. Other compounds, such as 4‐hydroxytamoxifen and the “pure” anti‐oestrogen ICI 182,780, which are reported to inhibit EI‐STS activity in vitro, did not inhibit activity in vivo. In a preliminary study, EMATE, when injected over a 12‐day period, effectively reduced the growth of EI S‐stimulated nitrosomethyl‐urea‐induced mammary tumours in ovariectomised rats and inhibited tumour sulphatase activity in treated animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hobkirk, R. (1993) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(05)80018-9 · Cited by 113
Cited by
Steroid sulfatase: molecular biology, regulation, and inhibition
Reed, M. J., Purohit, A., Woo, L. W. L., Newman, S. P., & Potter, B. V. L. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0003 · Cited by 524
Self-citationThe selective estrogen enzyme modulators in breast cancer: a review
Pasqualini, J. R. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.03.001 · Cited by 192
“Estrone-3-O-sulfamate (EMATE) is a potent synthesized sulfatase inhibitor [90]: at a concentration of 10 7 M the estrone sulfatase activity in MCF-7 cells in inhibited by 99% [91,92].”
BackgroundSteroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
Purohit, A., & Foster, P. A. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0266 · Cited by 126
“It was EMATE that emerged as the lead compound in this series with an extremely potent STS inhibitor activity in MCF-7 cells (IC50 of 65 pM) (Purohit et al. 1995a, 1996a).”
Self-citationPotter, B. V. L. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0045 · Cited by 73
Self-citationInhibition of steroid sulfatase decreases endometriosis in an in vivo murine model
Colette, S., Defrere, S., Lousse, J. C., Van Langendonckt, A., Gotteland, J. P., Loumaye, E., & Donnez, J. (2011) · Human Reproduction · doi:10.1093/humrep/der079 · Cited by 45
Metadata
- Authors
- Purohit, A., Williams, G. J., Roberts, C. J., Potter, B. V. L., & Reed, M. J.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1995-09-27
- Volume
- 63
- Issue
- 1
- Pages
- 106-111
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2036000871
- Cited by
- 76
- References
- 1
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone‐3‐O‐sulphamate. https://app.cochat.ai/papers/10.1002/ijc.2910630119
- The paper
- Purohit, A., Williams, G. J., Roberts, C. J., Potter, B. V. L., & Reed, M. J. (1995). In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone‐3‐O‐sulphamate. International Journal of Cancer. https://doi.org/10.1002/ijc.2910630119
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.